CHATSWORTH, Calif., May 9, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that Chairman, President and Chief Executive Officer César García, is scheduled to present an overview of the Company at the 7th Annual Spring Growth Stock Conference hosted by Security Research Associates, Inc. The conference will take place on Tuesday, May 24, 2011 at the Omni Hotel in San Francisco.
Mr. García is scheduled to speak at 1:00 p.m. Pacific time and, along with CFO Amin Khalifa, will also be available for one-on-one meetings with institutional and accredited investors at the conference throughout the day on May 24. Investors interested in scheduling a one-on-one meeting are asked to contact firstname.lastname@example.org.
About IRIS International, Inc.
IRIS International, Inc. is a leading global in vitro diagnostics company focused on products that analyze particles and living cell forms and structures, or morphology of a variety of body fluids. The Company's products leverage its strengths in flow imaging technology, particle recognition and automation to bring efficiency to hospital and commercial laboratories. The initial applications for its technology have been in the urinalysis market and the Company is the leading worldwide provider of automated urine microscopy and chemistry systems, with an installed base of more than 3,100 systems in more than 50 countries. The Company is expanding its core imaging and morphology expertise into related markets and is developing applications in hematology and body fluids. In addition, the Company recently acquired a high complexity CLIA-certified molecular pathology laboratory offering differentiated, high value molecular diagnostic services in the rapidly growing field of personalized medicine. The laboratory provides a direct commercial channel for the Company's NADiA® ultra-sensitive nucleic acid detection immunoassay platform, with applications in oncology and infectious disease. For more information, please visit .
About Security Research Associates, Inc.
Security Research Associates, Inc. (SRA) was founded in San Francisco in 1980 and, today, offers investment banking and M&A services as well as institutional brokerage services. A boutique firm by design, SRA works with a select group of portfolio managers from around the country and focuses on technology and life science companies in the micro and small cap arenas. For more information about SRA see our web site at or call us at 415-925-0346.
CONTACT: Cesar Garcia, Chairman, President and Chief Executive Officer IRIS International, Inc. 818-527-7000 Ron Stabiner, The Wall Street Group, Inc. 212-888-4848